Warburg effect modulated by deubiquitinating enzymes and their substrates (WP5216)
Homo sapiens
Even in the presence of oxygen, cancer cells convert glucose to lactate as their main source for energy production, instead of using the citric acid cycle and oxidative phosphorylation. This process is called the Warburg effect. This pathway shows the effects deubiquitinating enzymes (DUBs) and their substrates have. DUBs free proteins of their ubiquitin chain, so that the proteins can resume their function in the cells rather than be degraded by the ubiquitin-proteasome system (UPS). The deubiquitination of VHL via OTUD6B (part of a DUB subfamily) represses HIF-1α, whereas the direct deubiquitination of HIF-1a via DUBs leads to the increased expression of GLUT1 and VEGF. The transcription factor c-Myc helps regulate gene expression involved in the glucose metabolism (e.g., GLUT1, HK2, LDHA) and is stabilised by ubiquitin-specific proteases. The PI3K/Akt pathway is also upregulated by deubiquitination of VEGF and Akt. This entails cell growth and apoptosis regulation, as well as promoted glucose transport to cancer cells and activating mTor, which improves glycolysis. It is shown in this pathway, how deubiquitinating enzymes play an important role in stabilizing different proteins, acting as oncoproteins and tumor suppressors equally. This pathway is based on figure 3 featured in “Regulation of Cancer Metabolism by Deubiquitinating Enzymes: The Warburg Effect” by So-Hee Kim and Kwang-Hyun Baek.
Authors
Andra Waagmeester , Eric Weitz , Egon Willighagen , and Marlen mActivity
Discuss this pathway
Check for ongoing discussions or start your own.
Cited In
Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.
Organisms
Homo sapiensCommunities
CPTACAnnotations
Pathway Ontology
glycolysis pathwayDisease Ontology
cancerLabel | Type | Compact URI | Comment |
---|---|---|---|
F1,6BP | Metabolite | chebi:32966 | |
GA3P | Metabolite | chebi:17138 | |
1,3-BPG | Metabolite | chebi:89363 | |
3PG | Metabolite | chebi:17050 | |
Pyruvate | Metabolite | chebi:15361 | |
Lactate | Metabolite | chebi:24996 | |
Glucose | Metabolite | chebi:4167 | |
PEP | Metabolite | chebi:18021 | |
G6P | Metabolite | chebi:4170 | |
F6P | Metabolite | chebi:61527 | |
2PG | Metabolite | chebi:24344 | |
SIRT7 | GeneProduct | ncbigene:51547 | |
OTUB2 | GeneProduct | ncbigene:78990 | |
FOXO1 | GeneProduct | ncbigene:2308 | |
AKT1 | GeneProduct | ncbigene:207 | |
HK2 | GeneProduct | ensembl:ENSG00000159399 | |
USP7 | GeneProduct | ncbigene:7874 | |
OTUD6B | GeneProduct | ncbigene:51633 | |
c-Myc | GeneProduct | ensembl:ENSG00000136997 | |
PGK1 | GeneProduct | ncbigene:5230 | |
LDHA | GeneProduct | ncbigene:3939 | |
GLUT1 | GeneProduct | ensembl:ENSG00000117394 | |
USP28 | GeneProduct | ncbigene:57646 | |
VHL | GeneProduct | ensembl:ENSG00000134086 | |
FBP1 | GeneProduct | hgnc.symbol:FBP1 | |
PI3K | GeneProduct | ensembl:ENSG00000121879 | |
PGAM1 | GeneProduct | ncbigene:5223 | |
USP44 | GeneProduct | ncbigene:84101 | |
OTUD7B | GeneProduct | ncbigene:56957 | |
MTOR | GeneProduct | ncbigene:2475 | |
HIF-1α | GeneProduct | ncbigene:3091 | |
USP19 | GeneProduct | ncbigene:10869 | |
G6PC | GeneProduct | ncbigene:2538 | |
U2AF2 | GeneProduct | ncbigene:11338 | |
VEGF | GeneProduct | ensembl:ENSG00000112715 | |
USP37 | GeneProduct | ncbigene:57695 | |
VEGFR2 | GeneProduct | ensembl:ENSG00000128052 |
References
- Regulation of Cancer Metabolism by Deubiquitinating Enzymes: The Warburg Effect. Kim SH, Baek KH. IJMS [Internet]. 2021 Jun 8;22(12):6173. Available from: http://dx.doi.org/10.3390/IJMS22126173 DOI Scholia
- Phosphoenolpyruvate: An end to hand-waving. Behrman EJ, Gopalan V. Biochem Mol Biol Educ. 2008 Sep;36(5):323–4. PubMed Europe PMC Scholia
- VEGFA and tumour angiogenesis. Claesson-Welsh L, Welsh M. J Intern Med. 2013 Feb;273(2):114–27. PubMed Europe PMC Scholia
- PIK3CA in cancer: The past 30 years. Arafeh R, Samuels Y. Semin Cancer Biol. 2019 Dec;59:36–49. PubMed Europe PMC Scholia